Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: ALTRAZEAL LIFE SCIENCES INC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-02-07 to 2027-05-05
Current total value of award: $1300000
Description: DHA SBIR SEQUENTIAL PHASE II, PROPOSAL NO. H2S-0071, TITLED: "DEVELOPING AN IDEAL FIRST USE AGENT TO PREVENT SEPSIS IN TRAUMA WOUNDS DURING CARE UNDER FIRE."